Gainers & Losers
Fri Jun 20 2025 10:16:01- Bharti Airtel share price
- ₹1,936.953.27%
- Mahindra And Mahindra share price
- ₹3,182.302.93%
- Power Grid Corporation Of ...
- ₹293.102.38%
- Reliance Industries share price
- ₹1,464.652.16%
- Nestle India share price
- ₹2,364.651.97%
Active Stocks
Fri Jun 20 2025 10:26:29- Bharat Electronics share price
- ₹408.052.38%
- Zee Entertainment Enterpri...
- ₹132.954.19%
- Itc share price
- ₹418.450.59%
- Reliance Industries share price
- ₹1,464.652.16%
- Indian Oil Corp share price
- ₹138.650.04%
Business News/Market/Market Stats/Emcure Pharmaceuticals share price/ Emcure Pharmaceuticals Profit Loss Annual
Emcure Pharmaceuticals Profit & Loss Annual
1,310.10 -14.20 (-1.07%)Updated : 20 Jun 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Revenue | 7,896.00 | 6,658.25 | 5,985.81 | 5,855.39 |
| Total Revenue | 7,896.00 | 6,658.25 | 5,985.81 | 5,855.39 |
| Costof Revenue Total | 3,146.60 | 2,595.46 | 2,369.11 | 2,330.43 |
| Gross Profit | 4,749.39 | 4,062.79 | 3,616.70 | 3,524.95 |
| Selling/ General/ Admin Expenses Total | 1,446.29 | 1,913.31 | 1,605.41 | 1,408.80 |
| Depreciation/ Amortization | 384.13 | 312.41 | 260.12 | 244.86 |
| Unusual Expense( Income) | 10.38 | 9.93 | 6.15 | - |
| Other Operating Expenses Total | 1,834.25 | 919.76 | 829.78 | 785.84 |
| Total Operating Expense | 6,821.65 | 5,750.87 | 5,070.56 | 4,769.93 |
| Operating Income | 1,074.35 | 907.39 | 915.25 | 1,085.46 |
| Interest Inc( Exp) Net- Non- Op Total | -170.26 | -166.08 | -153.03 | -96.58 |
| Other Net | 67.26 | -21.27 | -14.68 | -15.92 |
| Net Income Before Taxes | 971.35 | 727.23 | 747.21 | 972.55 |
| Provisionfor Income Taxes | 263.88 | 199.65 | 185.37 | 269.99 |
| Net Income After Taxes | 707.47 | 527.58 | 561.85 | 702.56 |
| Minority Interest | -26.14 | -29.39 | -29.83 | -40.36 |
| Net Income Before Extra Items | 681.33 | 498.18 | 532.02 | 662.20 |
| Net Income | 681.33 | 498.18 | 532.02 | 662.20 |
| Income Availableto Com Excl Extra Ord | 681.33 | 498.18 | 532.02 | 662.20 |
| Income Availableto Com Incl Extra Ord | 681.33 | 498.18 | 532.02 | 662.20 |
| Diluted Net Income | 681.33 | 498.18 | 532.02 | 662.20 |
| Diluted Weighted Average Shares | 18.70 | 18.91 | 18.91 | 18.91 |
| Diluted EPS Excluding Extra Ord Items | 36.43 | 26.35 | 28.13 | 35.02 |
| DPS- Common Stock Primary Issue | 3.00 | - | - | - |
| Diluted Normalized EPS | 36.83 | 26.45 | 28.39 | 35.03 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| period Type | - | - | - | - |
| Gain( Loss)on Saleof Assets | - | 7.19 | -0.33 | -0.41 |
*All figures in crores except per share values
Emcure Pharmaceuticals Quick Links
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Balance Sheet Emcure Pharmaceuticals Cashflow Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,936.95+61.35(3.27%)
3,182.30+90.50(2.93%)
293.10+6.80(2.38%)
12,803.60-2.55 (-0.02%)